Latest Senior Health News


1 in 5 U.S. Seniors Now Skip Meds Because of Cost

1 in 5 U.S. Seniors Now Skip Meds Because of CostMONDAY, May 22, 2023 (HealthDay News) -- Many seniors skip or stretch prescription medications due to costs despite being insured by Medicare, a new U.S. study finds. Roughly 20% of older adults reported taking less medication than prescribed or not taking medication because of cost, the researchers found. "We also found that most respondents wanted to talk with their doctors about medication costs and would want their doctor to use tools to estimate their medication prices if they were available, " said lead researcher Stacie Dusetzina, a professor of health policy at Vanderbilt University in Nashville, Tenn.For the study, Dusetzina and her colleagues surveyed more than 2,000 men and women age 65 and older, via phone and online. Among those taking part in the survey, 20% said cost...

New 'National Sports Brain Bank' Will Boost Head Injury...

19 May 2023
New `National Sports Brain Bank` Will Boost Head Injury ResearchFRIDAY, May 19, 2023 (HealthDay News) -- A new brain bank is accepting future donations from living athletes, in an effort to perform long-term research into the effects of sports-related concussion.The National Sports Brain Bank (NSBB) at the University of Pittsburgh will track the health of living participants on an annual basis, and will autopsy their donated brains after their death.“We want to follow prospective donors longitudinally while they're still alive and get information from them about their sports participation, trauma, history, other medical history, any symptoms they may experience,” said NSBB Director Dr. Julia Kofler.“We can then correlate their clinical information with what we see down the road under the microscope, at the time of autopsy,” she said.Two...

Stroke Gaining Ground as a Global Killer

19 May 2023
Stroke Gaining Ground as a Global KillerFRIDAY, May 19, 2023 (HealthDay News) -- Worldwide deaths from the most common type of stroke have risen significantly in the past three decades and will increase even more sharply in the years ahead, researchers say.Ischemic stroke deaths grew from 2 million in 1990 to more than 3 million in 2019. They are expected to reach nearly 5 million by 2030, according to a report published online May 17 in the journal Neurology.Ischemic strokes are caused by a blockage of blood flow to the brain. “This increase in the global death toll of ischemic stroke along with a predicted further increase in the future is concerning, but ischemic stroke is highly preventable,” said study author Dr. Lize Xiong, of Tongji University in Shanghai, China. “Our results suggest that a combination of...

At Least 10 Pesticides Could Have Links to Parkinson's

19 May 2023
At Least 10 Pesticides Could Have Links to Parkinson`sFRIDAY, May 19, 2023 (HealthDay News) -- Scientists say they've identified 10 pesticides that kill neurons involved in Parkinson's disease, marking a leap forward in their understanding of the movement disorder.Pesticide exposure has long been associated with Parkinson's, but investigators hadn't been able to pinpoint specific culprits.A team from the University of California, Los Angeles and Harvard University paired epidemiology and toxicity screening to isolate which among the many thousands of pesticide products could be involved.“We were able to implicate individual agents more than any other study has before," Kimberly Paul said in a UCLA news release. Paul is a lead author of the study and an assistant professor of neurology at UCLA. The 10 pesticides her team identified...

Drug May Offer New Approach Against Rheumatoid Arthritis

18 May 2023
Drug May Offer New Approach Against Rheumatoid ArthritisTHURSDAY, May 18, 2023 (HealthDay News) -- An investigational drug may hit the reset button on a faulty immune system for some people with rheumatoid arthritis.Rheumatoid arthritis, or RA, is an autoimmune disease that occurs when the body misfires against its own joints and tissues, causing joint pain, stiffness, fatigue and other symptoms.The drug, peresolimab, is a monoclonal antibody that stimulates human programmed cell death protein 1 (PD-1), which serves as the brakes on the immune system, said study author Dr. Ajay Nirula. He's vice president of immunology for Lilly Research Laboratories in San Diego, which is developing peresolimab. It funded the new research, which was published May 17 in the New England Journal of Medicine.PD-1 is a protein found on T cells that helps keep...

Copyright © 2018 HealthDay. All rights reserved.